AnalystsBill Maughan
Bill Maughan's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 9%
#5067 out of 5510 analysts
Average Return
-8.42%
Win Rate
37%7 out of 19
Risk vs Reward
Poor
Good

Bill Maughan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Dianthus Therapeutics IncDNTH
+175.31%$38.88$107.04
2025-09-17 -
2026-09-09
Strong Buy
Krystal Biotech IncKRYS
+167.37%$139.01$371.67
2025-07-01 -
2026-06-30
Strong Buy
Merus NvMRUS
+129.26%$21.94$50.30
2023-11-02 -
2024-11-01
Strong Buy
Dianthus Therapeutics IncDNTH
+23.15%$86.92$107.04
2026-03-10 -
2026-09-09
Strong Buy
Korro Bio IncKRRO
+10.51%$11.70$12.93
2026-02-19 -
2026-09-09
Strong Buy

Bill Maughan Analyst Color

Get additional color on Bill Maughan's coverage of popular stocks

Bill Maughan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Dianthus Therapeutics IncDNTH
2Strong Buy$130.00+21.45%Maintains
6 months ago
Ocular Therapeutix IncOCUL
1Strong Buy$28.00+144.12%Maintains
6 months ago
Korro Bio IncKRRO
2Strong Buy$18.00+39.21%Upgrades
7 months ago
Caribou Biosciences IncCRBU
1Strong Buy$13.00+802.78%Initiates Coverage On
7 months ago
Cellectis SaCLLS
1Strong Buy$9.00+187.54%Initiates Coverage On
9 months ago
Wave Life Sciences IncWVE
2Strong Buy$47.00+877.13%Maintains
9 months ago
Annexon IncANNX
1Strong Buy$17.00+289.02%Initiates Coverage On
9 months ago
Y Mabs Therapeutics IncYMAB
3Hold$8.60N/ADowngrades
a year ago
Krystal Biotech IncKRYS
1Strong Buy$190.00N/AInitiates Coverage On
a year ago
Crispr Therapeutics AgCRSP
1Hold$45.00N/ADowngrades
a year ago
Nkarta IncNKTX
2Strong Buy$15.00N/AMaintains
2 years ago
Fate Therapeutics IncFATE
1Strong Buy$9.00N/AMaintains
2 years ago
Immunocore Holdings PLCIMCR
3Hold$67.00N/AMaintains
2 years ago
Moderna IncMRNA
3Hold$106.00N/AMaintains
2 years ago
Century Therapeutics IncIPSC
1Strong Buy$24.00N/AMaintains
2 years ago
Bicycle Therapeutics PLCBCYC
1Strong Buy$60.00N/AReiterates
3 years ago
Merus NvMRUS
1Strong Buy$45.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.